6 employees
Metallo Bio's focus is on the development of two lead chemicals that represent a pioneering new class of antibiotics.
2021
$331K
from 3 investors over 3 rounds
MetalloBio raised $331K on October 1, 2022
Investors: Innovate UK
MetalloBio raised $36K on June 29, 2022
Investors: - and Innovate UK